<DOC>
	<DOCNO>NCT01775579</DOCNO>
	<brief_summary>We investigate potential pharmacokinetic drug-drug interaction metformin extend release rosuvastatin healthy male volunteer receive metformin extend release alone , rosuvastatin alone , together 3 period repeatedly .</brief_summary>
	<brief_title>Evaluating Pharmacokinetic Drug Interaction Between Metformin Hydrochloride Rosuvastatin Calcium</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Healthy male volunteer , age 20 55 year . 2 . The result Body Mass Index ( BMI ) less 19 kg/m2 , 27 kg/m2 3 . Subjects ability comprehend objective , content study property study drug participate trial willingness sign inform consent write 1 . Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study , include clinically significant disorder kidney , liver , cardiovascular system , respiratory system , endocrine system , neuropsychiatric system . 2 . Glomerular filtration rate 60ml/min calculate serum creatinine value . 3 . Liver enzyme ( AST , ALT ) level exceed one half time maximum normal range . 4 . Systolic blood pressure &lt; 90mmHg Diastolic blood pressure &lt; 60 mmHg , systolic blood pressure ≥ 140 mmHg diastolic blood pressure ≥ 90 mmHg ( Sitting blood pressure ) screening procedure .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>